Cutler Group LP Myovant Sciences Ltd. Put Options Transaction History

Cutler Group LP

7 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q4 2022 Feb 07, 2023	SELL	$24.03 - $27.02 $194,643 - $218,862	-8,100 Reduced 91.01%	800 $0
Q3 2022 Oct 25, 2022	BUY	$11.6 - $20.44 $103,240 - $181,916	8,900 New	8,900 $5,000
Q1 2021 Apr 26, 2021	SELL	$20.46 - $25.18 $47,058 - $57,914	-2,300 Reduced 62.16%	1,400 $0
Q4 2020 Jan 21, 2021	SELL	$13.8 - $27.62 $13,800 - $27,620	-1,000 Reduced 21.28%	3,700 $1,000
Q3 2020 Oct 27, 2020	BUY	$14.05 - $22.6 $37,935 - $61,020	2,700 Added 135.0%	4,700 $18,000
Q2 2020 Jul 22, 2020	SELL	$7.34 - $20.84 $7,340 - $20,840	-1,000 Reduced 33.33%	2,000 $2,000
Q4 2019 Feb 06, 2020	BUY	$4.2 - $19.21 $12,600 - $57,630	3,000 New	3,000 $13,000

61.3K

Ticker MYOV
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 96,802,800
Description
Myovant Sciences Ltd., a biopharmaceutical company, develops redefine care for women and for men. The company's lead product is relugolix, an oral, once-daily, small molecule that acts as a gonadotropin-releasing hormone receptor antagonist for the treatment of heavy menstrual bleeding related with uterine fibroids, endometriosis-associated pain...

Get notified when there are updates to the investment portfolio of Cutler Group LP, based on Form 13F filings with the SEC.

Stay updated on Cutler Group LP with notifications on news.